Sussex Partner Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
      • 13.1 Dry and scaling skin disorders
      • 13.2 Infections of the skin
      • 13.3 Inflammatory skin conditions
      • 13.4 Perspiration
      • 13.5 Pruritus
      • 13.6 Rosacea and acne
      • 13.7 Scalp and hair conditions
      • 13.8 Skin cleansers, antiseptics and desloughing agents
      • 13.9 Skin disfigurement
      • 13.10 Sun protection and photodamage
      • 13.11 Superficial soft-tissue injuries and superficial thrombophlebitis
      • 13.12 Warts and calluses
      • 13.13 Other Skin items
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Actinic Keratosis – Primary Care treatment preferred options based on PCDS flow chart

Diclofenac

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Solaraze 3% gel

Pack
50 gram
100 gram

Fluorouracil

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Efudix 5% cream

Pack
20 gram
40 gram

Fluorouracil + Salicylic acid

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Actikerall 5mg/g / 100mg/g cutaneous solution

Pack
25 ml

Imiquimod

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Zyclara 3.75% cream 250mg sachets

Pack
28 sachet

Tirbanibulin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Klisyri 10mg/g ointment 250mg sachets

Pack
5 sachet

Uvistat

Over the Counter { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

OTC except if ACBS indication.

Uvistat sun cream SPF 30

Pack
125 ml

Uvistat sun cream SPF 50

Pack
125 ml

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2025